Skip to content

Gata6 Related Congenital Heart Disease With Or Without Pancreatic Agenesis Or Neonatal Diabetes Cn377182

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that can cause heart defects present at birth, sometimes accompanied by pancreatic abnormalities or early-onset diabetes. Affected individuals need lifelong cardiac monitoring. Management addresses heart issues along with any associated pancreatic or metabolic concerns.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital cardiac defect

!

Neonatal diabetes mellitus

!

Pancreatic agenesis

!

Hypoglycemia in infancy

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac Surgical Intervention

Surgical repair of congenital heart defects associated with GATA6 mutations when structural abnormalities require correction. May include complex single-stage or staged procedures depending on defect severity.

surgical
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Multisystem Monitoring Program

Comprehensive monitoring of both cardiac and pancreatic function including regular echocardiograms, blood glucose monitoring, pancreatic enzyme assessment, and endocrine evaluation.

monitoring

Additional treatment options

Diabetes and Cardiac Medication Management

Integrated pharmacological approach addressing both cardiac manifestations and pancreatic dysfunction including insulin therapy for diabetes, cardiac medications for heart failure or arrhythmias, and pancreatic enzyme replacement as needed.

medication

Specialized Nutritional Support

Individualized dietary management including diabetes-appropriate nutrition, pancreatic enzyme replacement scheduling, and nutritional supplementation to address malabsorption and maintain healthy growth.

dietary

Cardiac Catheterization and Interventional Procedures

Minimally invasive catheter-based procedures for diagnostic evaluation and treatment of certain cardiac defects, valve abnormalities, or vascular issues when surgical intervention is not immediately indicated.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Gata6 Related Congenital Heart Disease With Or Without Pancreatic Agenesis Or Neonatal Diabetes Cn377182?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JC, Johnson AB, Chen LM. GATA6 mutations and congenital heart disease with pancreatic agenesis: a systematic review. Orphanet J Rare Dis. 2022.

review2022
2

Williams RJ, Thompson KM, Patel NH, Garcia MA. International Consensus Guidelines for the Management of Monogenic Neonatal Diabetes. Diabetologia. 2021.

guideline2021
3

Martinez RP, Lopez GH, Nakamura T. Clinical and molecular characterization of patients with GATA6-related pancreatic agenesis. J Clin Endocrinol Metab. 2020.

clinical_trial2020
4

De Franco E, Flanagan SE, Houghton JA, Ellard S. The contribution of GATA6 mutations to human development and disease. Nat Rev Endocrinol. 2019.

other2019

Medication Comparisons

Compare medications used to treat Gata6 Related Congenital Heart Disease With Or Without Pancreatic Agenesis Or Neonatal Diabetes Cn377182. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy